DaVita (DVA) witnessed strong momentum year to date. Shares of the company rallied 34.5% compared with 11.2% growth of the industry in the same time frame. The S&P 500 Composite has risen 11.7% during the same period. With healthy fundamentals and strong growth opportunities, this Zacks Rank #2 (Buy) company appears to be a solid wealth creator for its investors at the moment. Denver, CO-headquartered DaVita is a leading provider of dialysis services in the United States to patients suffering from chronic k ...